Crown Castle International Corp. (0I4W)
London Stock Exchange · UK · prices in USD · close of 27 Oct 2026
Key indicators
| Last close | USD 86.93 |
|---|---|
| 52-week range | 65.40 – 98.08 |
| Return, 1 month / 3 months | +28.6% / +19.1% |
| Return, 1 year / 3 years | −6.3% / +13.8% |
| Trend | Uptrend |
| RSI (14) | 69 |
| Volatility (1 year) | 34.0% |
| Worst drawdown (1 year) | -29.4% |
| Average daily value traded | 0.15M USD |
| Dividend yield | 4.9% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Crown Castle International Corp. owns and leases communications infrastructure, chiefly wireless towers and small-cell networks, to mobile phone operators and other wireless service providers across the United States. The company also provides fiber connectivity for cellular and enterprise networks. It operates as a real estate investment trust and is based in Houston, Texas, serving carriers that need sites and structures for their networks.
On this site Crown Castle International Corp. appears as a stock on the London Stock Exchange (UK), code 0I4W, with prices in US dollars (USD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Crown Castle International Corp. (0I4W) trades on the London Stock Exchange in UK. It last closed at USD 86.93 on 27 October 2026.
Its price-based Market X-Ray is 53 out of 100 (a fair price profile), ranking 1,891 of 3,788 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 6.3% and over the last three months it rose 19.1%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 54 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 7.9% | ||
| From 52-week high | -10.8% | ||
| Momentum | 54 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 19.1% | ||
| 6-month return | 5.6% | ||
| 12-month return, skipping the last month | -27.1% | ||
| Stability (higher is calmer) | 51 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 34.0% | ||
| Worst drawdown, 1 year (smaller is calmer) | -29.4% | ||
| Liquidity | 34 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.15M USD | ||
| Zero-volume days | 0.0% | ||
| Income | 80 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 4.9% | ||
| Years with dividends | 6 |
Strengths
- Income: Dividend is high and has been paid regularly.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +5.9% |
|---|---|
| 1 month | +28.6% |
| 3 months | +19.1% |
| 6 months | +5.6% |
| 1 year | −6.3% |
| 3 years | +13.8% |
| 5 years | −37.5% |
Signals
| 50-day / 200-day average | 74.61 / 80.57 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 3.77 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 14 Sep 2026 | USD 1.0625 |
| 12 Jun 2026 | USD 1.0625 |
| 12 Mar 2026 | USD 1.0625 |
| 12 Dec 2025 | USD 1.0625 |
| 12 Sep 2025 | USD 1.0625 |
| 12 Jun 2025 | USD 1.0625 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.